These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome. Shrestha R; Durham JD; Wachs M; Bilir BM; Kam I; Trouillot T; Everson GT Am J Gastroenterol; 1997 Dec; 92(12):2304-6. PubMed ID: 9399778 [TBL] [Abstract][Full Text] [Related]
43. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients]. Yang CS; Cao SY; He XJ; Wang YX; Zhang YL Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712 [TBL] [Abstract][Full Text] [Related]
44. Pharmacotherapy of hepatic encephalopathy in cirrhosis. Romero-Gómez M Expert Opin Pharmacother; 2010 Jun; 11(8):1317-27. PubMed ID: 20384539 [TBL] [Abstract][Full Text] [Related]
46. Living related liver transplantation in Crigler-Najjar syndrome type 1. Ozçay F; Alehan F; Sevmiş S; Karakayali H; Moray G; Torgay A; Arslan G; Haberal M Transplant Proc; 2009 Sep; 41(7):2875-7. PubMed ID: 19765461 [TBL] [Abstract][Full Text] [Related]
47. Liver transplantation for acute hepatic failure: a review of clinical experience and management. Smith SL; Ciferni M Am J Crit Care; 1993 Mar; 2(2):137-44. PubMed ID: 8358462 [TBL] [Abstract][Full Text] [Related]
49. Neurologic complications of liver transplantation in pediatric patients with the hepatic form of Wilson's disease. Erol I; Alehan F; Ozcay F; Canan O; Haberal M J Child Neurol; 2008 Mar; 23(3):293-300. PubMed ID: 18079318 [TBL] [Abstract][Full Text] [Related]
50. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230 [TBL] [Abstract][Full Text] [Related]
51. [Hepatic encephalopathy--therapy]. Wettstein M; Häussinger D Dtsch Med Wochenschr; 2003 Dec; 128(50):2658-60. PubMed ID: 14673743 [No Abstract] [Full Text] [Related]
52. Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions. Suraweera D; Sundaram V; Saab S Gut Liver; 2016 Jul; 10(4):509-19. PubMed ID: 27377741 [TBL] [Abstract][Full Text] [Related]
53. [Diagnostics and treatment of hepatic encephalopathy]. Gillmann A; Gerharz CD; Müssig K Dtsch Med Wochenschr; 2012 Jan; 137(1-2):29-33. PubMed ID: 22180281 [TBL] [Abstract][Full Text] [Related]
54. Management of hepatic encephalopathy: role of rifaximin. Zeneroli ML; Avallone R; Corsi L; Venturini I; Baraldi C; Baraldi M Chemotherapy; 2005; 51 Suppl 1():90-5. PubMed ID: 15855752 [TBL] [Abstract][Full Text] [Related]
55. Care of the liver transplant candidate. Tan HH; Martin P Clin Liver Dis; 2011 Nov; 15(4):779-806. PubMed ID: 22032529 [TBL] [Abstract][Full Text] [Related]
56. Management of hepatic encephalopathy: focus on antibiotic therapy. Festi D; Vestito A; Mazzella G; Roda E; Colecchia A Digestion; 2006; 73 Suppl 1():94-101. PubMed ID: 16498257 [TBL] [Abstract][Full Text] [Related]
57. Hepatic Encephalopathy. Gow AG Vet Clin North Am Small Anim Pract; 2017 May; 47(3):585-599. PubMed ID: 28069286 [TBL] [Abstract][Full Text] [Related]
58. Antibiotics for the treatment of hepatic encephalopathy. Patidar KR; Bajaj JS Metab Brain Dis; 2013 Jun; 28(2):307-12. PubMed ID: 23389621 [TBL] [Abstract][Full Text] [Related]